|
Recent Newsletters
Week in Review: Expanded coverage for AI-based coronary plaque assessments | Compensation climbs | STEMI recommendations |
Week in Review: The top children's heart hospitals | Flurpiridaz vs. SPECT | Medtronic's new Class I recall | J&J's big move |
Week in Review: FDA approves flurpiridaz | Intermittent fasting good for the heart | Docs accused of negligence | AI for CCTA |
September's Top Stories: A historic procedure | Private practice sues hospital | FDA approves radiotracer | TAVR bests SAVR |
Week in Review: Tracking Class I recalls | AI IDs hypertension | FTC sues over insulin | LBBAP & TAVR |
Week in Review: World's first fully robotic heart transplant | AR & VR in cardiology | IVUS vs. OCT | Much more |
Week in Review: Imaging patients with implanted devices | FDA clears AI platform | Cardiologist heads to prison | Much more |